← Evidence map

ArticleCureus2025

Understanding Treatment Completion and Tolerability of Intravesical Bacillus Calmette-Guérin (BCG) for Non-muscle Invasive Bladder Cancer in a Single UK Health Board.

Sami Mohammed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Understanding Treatment Completion and Tolerability of Intravesical Bacillus Calmette-Guérin (BCG) for Non-muscle Invasive Bladder Cancer in a Single UK Health Board. | OpenQuestion